The accused Munir Khan was held in a joint operation by the FDA and the police, for contravening various provision of Drugs and Cosmetics Act, FDA Commissioner Hrashadeep Kamble told PTI.
FDA has charged Khan with contravention of various sections under Drugs and Magic Remedies (Objectionable Advertisement) Act 1954 for advertising his product called 'Body Revival' claiming to cure various ailments and diseases such as heart disease, diabetes, tumor, epilepsy and making falls and misleading claims, he said.
On receiving a tip-off that Khan was indulging in dispensing spurious drugs, a team of FDA officers raided his premises at Versova, in Andheri West. The team found that Khan was selling his product 'Body Revival' for Rs 15,750 per bottle of 100 ml, Kamble said.
The sample was drawn for test and analysis and the stock worth Rs. 3.3 crore was prohibited as it was suspected to be of "not of standard quality".
It was found that Khan continued to advertise his product on electronic media and claimed to treat and cure ailments, diseases, disorders such as heart disease, diabetes, premature ageing, hypertension etc, Kamble said.
Khan was manufacturing the product earlier in Rajasthan, and the license to manufacture Body Revival was cancelled by Licensing Authority, Rajasthan on information passed on by FDA Maharashtra.
Later, he shifted the activity to Himachal Pradesh and "procured license" for the product. He has continued to "exploit and deceive" the patients suffering from chronic diseases and disorders by charging exorbitantly for a formulation of which manufacturing cost would not be more than Rs 100.
The accused has had several run-ins with the law and in 2009 was absconding after selling fake cancer drug, the FDA said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
